ICH Study Center GmbH & Co. KG

At ICH Study Center GmbH & Co. KG in Hamburg, a major focus is HIV and HIV-1 infection, with studies looking at better ways to treat both people starting therapy and those already doing well on treatment. The research is centered on improving treatment effectiveness, maintaining viral suppression, and exploring simpler long-term options for patients.

• Testing new oral treatment combinations for HIV-1
• Evaluating switches from standard therapy to newer regimens
• Studying treatment effectiveness in treatment-naïve and virologically suppressed adults

These trials aim to make antiretroviral therapy more convenient while preserving strong control of the infection.

The site also conducts research in virus diseases affecting the liver, especially chronic hepatitis B, hepatitis B, and chronic hepatitis D infection. The studies are designed to assess new approaches that may improve long-term disease control and move closer to functional cure goals.

• Investigating therapies for chronic hepatitis B in patients already on treatment
• Assessing treatment switches for chronic hepatitis D
• Tracking durability of response in long-term follow-up studies

These projects reflect a strong interest in better management of persistent viral liver infections and in finding more durable treatment outcomes.

Another active area is herpes simplex research, where trials are examining whether targeted immunotherapy can reduce recurrent genital herpes episodes and improve protection against future outbreaks. The goal is to evaluate both safety and the potential benefit of new preventive approaches.

• Studying immune response and safety in herpes simplex research
• Testing whether a new vaccine approach can lower recurrence risk
• Exploring improved prevention for people with recurrent genital herpes

This work supports the development of better tools for managing a common and often recurring viral condition.

Research at the site also includes immune system processes, especially studies in psoriasis vulgaris and psoriatic arthritis. These trials are focused on understanding how vaccination or other interventions affect disease activity and immune response in people living with inflammatory conditions.

• Evaluating safety in patients with psoriasis or psoriatic arthritis
• Observing whether immune responses remain stable during treatment
• Supporting research on inflammation-related disease management

The ICH Study Center GmbH & Co. KG contributes to studies that aim to balance immune protection with control of underlying disease activity.